These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 10528831

  • 1. Differential diagnosis of endometrial hyperplasia and carcinoma by computerized image cytometry of cell proliferation, apoptosis and Bcl-2 expression.
    Mora LB, Diaz JI, Cantor AB, Nicosia SV.
    Ann Clin Lab Sci; 1999; 29(4):308-15. PubMed ID: 10528831
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
    Ma XX, Zhang SL, Gao S, Lu JM, Dong F.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
    [Abstract] [Full Text] [Related]

  • 7. The value of curettage in diagnosis of endometrial hyperplasia.
    Xie X, Lu WG, Ye DF, Chen HZ, Fu YF.
    Gynecol Oncol; 2002 Jan; 84(1):135-9. PubMed ID: 11748989
    [Abstract] [Full Text] [Related]

  • 8. bcl-2 expression in endometrial hyperplasia and carcinoma.
    Niemann TH, Trgovac TL, McGaughy VR, Vaccarello L.
    Gynecol Oncol; 1996 Dec; 63(3):318-22. PubMed ID: 8946865
    [Abstract] [Full Text] [Related]

  • 9. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL.
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [Abstract] [Full Text] [Related]

  • 10. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma.
    Henderson GS, Brown KA, Perkins SL, Abbott TM, Clayton F.
    Mod Pathol; 1996 Apr; 9(4):430-8. PubMed ID: 8729985
    [Abstract] [Full Text] [Related]

  • 11. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process.
    Shah SS, Mazur MT.
    Int J Gynecol Pathol; 2008 Oct; 27(4):534-8. PubMed ID: 18753967
    [Abstract] [Full Text] [Related]

  • 12. Expression of cyclin D1 in endometrial hyperplasia and endometrial carcinoma.
    Choudhury M, Bansal S.
    Indian J Pathol Microbiol; 2007 Oct; 50(4):708-10. PubMed ID: 18306533
    [Abstract] [Full Text] [Related]

  • 13. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M, Shen K, Yang JX, Huang HF, Wu M, Pan LY, Lang JH, Lian LJ.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 and Ki-67 expression in normal, hyperplastic and neoplastic endometrium.
    Shevra CR, Ghosh A, Kumar M.
    J Postgrad Med; 2015 Apr; 61(1):15-20. PubMed ID: 25511212
    [Abstract] [Full Text] [Related]

  • 15. Utility of Ki-67, p53, Bcl-2, and Cox-2 biomarkers for low-grade endometrial cancer and disordered proliferative/benign hyperplastic endometrium by imprint cytology.
    Apostolou G, Apostolou N, Biteli M, Kavantzas N, Patsouris E, Athanassiadou P.
    Diagn Cytopathol; 2014 Feb; 42(2):134-42. PubMed ID: 23729350
    [Abstract] [Full Text] [Related]

  • 16. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y, Watanabe J, Jobo T, Kato N, Fujisawa T, Kamata Y, Kuramoto H.
    Anticancer Res; 2004 Feb; 24(4):2185-91. PubMed ID: 15330159
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 18. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps.
    Taylor LJ, Jackson TL, Reid JG, Duffy SR.
    BJOG; 2003 Sep 15; 110(9):794-8. PubMed ID: 14511960
    [Abstract] [Full Text] [Related]

  • 19. Dissociated expression of Bcl-2 and Ki-67 in endometrial lesions: diagnostic and histogenetic implications.
    Risberg B, Karlsson K, Abeler V, Lagrelius A, Davidson B, Karlsson MG.
    Int J Gynecol Pathol; 2002 Apr 15; 21(2):155-60. PubMed ID: 11917225
    [Abstract] [Full Text] [Related]

  • 20. bcl-2 expression and the development of endometrial carcinoma.
    Chhieng DC, Ross JS, Ambros RA.
    Mod Pathol; 1996 Apr 15; 9(4):402-6. PubMed ID: 8729980
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.